Zhifeng Han

635 total citations
18 papers, 363 citations indexed

About

Zhifeng Han is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhifeng Han has authored 18 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhifeng Han's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Zhifeng Han is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Zhifeng Han collaborates with scholars based in China, United Kingdom and United States. Zhifeng Han's co-authors include Haixiang Yu, Jinru Xue, Xin Hua, Hua Xin, Jingzhe Zhang, Lei Xu, Huan Zhao, Liping Ma, Li Li and Yinghao Zhao and has published in prestigious journals such as Scientific Reports, Cell Cycle and Phytotherapy Research.

In The Last Decade

Zhifeng Han

18 papers receiving 353 citations

Peers

Zhifeng Han
Wenying Deng China
Jing Zhuang China
Ailin Song China
Yangwei Xu China
Baixia Yang China
Kezhen Lv China
Dezhi Cheng China
Young-Soon Na South Korea
Jiyuan Yang China
Wenying Deng China
Zhifeng Han
Citations per year, relative to Zhifeng Han Zhifeng Han (= 1×) peers Wenying Deng

Countries citing papers authored by Zhifeng Han

Since Specialization
Citations

This map shows the geographic impact of Zhifeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifeng Han more than expected).

Fields of papers citing papers by Zhifeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifeng Han. The network helps show where Zhifeng Han may publish in the future.

Co-authorship network of co-authors of Zhifeng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifeng Han. A scholar is included among the top collaborators of Zhifeng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifeng Han. Zhifeng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Han, Zhifeng, et al.. (2023). Branchial cleft cyst arising in posterior mediastinum: A case report. Frontiers in Surgery. 9. 1088142–1088142. 1 indexed citations
2.
Zhang, Tinghe, Yu‐Chiao Chiu, Zhifeng Han, et al.. (2022). Transformer for Gene Expression Modeling (T-GEM): An Interpretable Deep Learning Model for Gene Expression-Based Phenotype Predictions. Cancers. 14(19). 4763–4763. 28 indexed citations
3.
Zhang, Weiran, et al.. (2022). Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326. Bioengineered. 13(6). 14472–14488. 3 indexed citations
4.
Han, Zhifeng, et al.. (2020). Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375. Cell Cycle. 19(17). 2139–2147. 12 indexed citations
5.
Han, Zhifeng, Jingzhe Zhang, Kun Zhang, & Yinghao Zhao. (2020). Curcumin inhibits cell viability, migration, and invasion of thymic carcinoma cells via downregulation of microRNA‐27a. Phytotherapy Research. 34(7). 1629–1637. 23 indexed citations
6.
Yao, Jianfei, Yuan Gong, Wei Zhao, et al.. (2019). Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population. Scientific Reports. 9(1). 15767–15767. 38 indexed citations
7.
Yu, Haixiang, Lei Xu, Zhengjia Liu, et al.. (2019). Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer. Canadian Respiratory Journal. 2019. 1–12. 9 indexed citations
8.
9.
Zhao, Huan, et al.. (2018). Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer. Scientific Reports. 8(1). 9847–9847. 8 indexed citations
10.
Zhao, Huan, Xuan Zhang, Zhifeng Han, & Yanjun Wang. (2018). Circulating anti‐p16a IgG autoantibodies as a potential prognostic biomarker for non‐small cell lung cancer. FEBS Open Bio. 8(11). 1875–1881. 10 indexed citations
11.
Zhao, Huan, Xuan Zhang, Zhifeng Han, Zhenqi Wang, & Yao Wang. (2018). Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer. FEBS Open Bio. 8(5). 829–835. 14 indexed citations
12.
Han, Zhifeng, et al.. (2018). Increased Levels of Circulating Anti-ANXA1 IgG Antibody in Patients with Non-Small Cell Lung Cancer. Clinical Laboratory. 64(06/2018). 895–900. 4 indexed citations
13.
Yu, Haixiang, et al.. (2018). Esophageal hiatal hernia: risk, diagnosis and management. Expert Review of Gastroenterology & Hepatology. 12(4). 319–329. 50 indexed citations
14.
Wang, Yan, et al.. (2015). Potential anti‐cancer effect of curcumin in human lung squamous cell carcinoma. Thoracic Cancer. 6(4). 508–516. 20 indexed citations
15.
Ma, Liping, Hongjun Peng, Kunsheng Li, et al.. (2015). Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis. Molecular Medicine Reports. 12(3). 4196–4202. 45 indexed citations
16.
Wang, Yue, et al.. (2015). MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression. Oncology Reports. 34(4). 1988–1994. 15 indexed citations
17.
Zhao, Wei, Haixiang Yu, Zhifeng Han, et al.. (2015). Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.. PubMed. 8(8). 9506–11. 29 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenying Deng Breakdown of academic impact, for papers by Jing Zhuang Breakdown of academic impact, for papers by Ailin Song Breakdown of academic impact, for papers by Yangwei Xu Breakdown of academic impact, for papers by Baixia Yang Breakdown of academic impact, for papers by Kezhen Lv Breakdown of academic impact, for papers by Dezhi Cheng Breakdown of academic impact, for papers by Young-Soon Na Breakdown of academic impact, for papers by Jiyuan Yang
Rankless by CCL
2026